drugset / Trial / NCT00855049
A Randomized Crossover Study to Determine the Pharmacokinetics of Intranasally Administered Acetaminophen in Healthy Adults
Withdrawn
University of Texas Southwestern Medical Center
American College of Medical Toxicology · collabMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · collab
RandomizedCrossoverOpen-labelBasic science
Summary
This study is being done to determine the systemic absorption of nasally inhaled acetaminophen (Tylenol®) versus orally ingested acetaminophen by comparing the serum drug concentrations of the two groups obtained at various times after study drug administration.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-12
- Completion
- 2009-12
Outcome
Outcome not reported
Stopped: “Unable to obtain FDA approval”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 500 mg | Intranasal |
Indications
No indication recorded.